Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phasesYe Guo, Jin Li, Yueyin Pan et al.|European Journal of Cancer|2022Cited by 57
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancerJin Li, Shukui Qin, Yuxian Bai et al.|Cancer Immunology Immunotherapy|2024Cited by 15